Literature DB >> 16909922

Hepcidin--a peptide hormone at the interface of innate immunity and iron metabolism.

T Ganz1.   

Abstract

Hepcidin is a cationic amphipathic peptide made in the liver, released into plasma and excreted in urine. Hepcidin is the homeostatic regulator of intestinal iron absorption, iron recycling by macrophages, and iron mobilization from hepatic stores, but it is also markedly induced during infections and inflammation. Under the influence of hepcidin, macrophages, hepatocytes, and enterocytes retain iron that would otherwise be released into plasma. Hepcidin acts by inhibiting the efflux of iron through ferroportin, the sole known iron exporter that is expressed in the small intestine, and in hepatocytes and macrophages. As befits an iron-regulatory hormone, hepcidin synthesis is increased by iron loading, and decreased by anemia and hypoxia. Hepcidin is also rapidly induced by cytokines, including IL-6. The resulting decrease in plasma iron levels eventually limits iron availability to erythropoiesis and contributes to the anemia associated with infection and inflammation. The decrease in extracellular iron concentrations due to hepcidin probably limits iron availability to invading microorganisms, thus contributing to host defense.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16909922     DOI: 10.1007/3-540-29916-5_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  46 in total

1.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

Review 2.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

3.  Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels.

Authors:  Oya Yonal; Filiz Akyuz; Kadir Demir; Sevgi Ciftci; Fahriye Keskin; Binnur Pinarbasi; Ahmet Uyanikoglu; Halim Issever; Sadakat Ozdil; Gungor Boztas; Fatih Besisik; Sabahattin Kaymakoglu; Yilmaz Cakaloglu; Zeynel Mungan; Atilla Okten
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

Review 4.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

5.  Do high blood hepcidin concentrations contribute to low ferritin levels in young tennis players at the end of tournament season?

Authors:  Ewa Ziemann; Katarzyna Kasprowicz; Anna Kasperska; Agnieszka Zembroń-Lacny; Jedrzej Antosiewicz; Radoslaw Laskowski
Journal:  J Sports Sci Med       Date:  2013-06-01       Impact factor: 2.988

6.  Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6/STAT3 signaling pathway.

Authors:  Zhong-Ming Qian; Xuan He; Tuo Liang; Ka-Chun Wu; Yik-Chun Yan; Li-Na Lu; Guang Yang; Qian Qian Luo; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2014-12       Impact factor: 5.590

7.  Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain.

Authors:  Qin Wang; Fang Du; Zhong-Ming Qian; Xiao Hu Ge; Li Zhu; Wing Ho Yung; Lei Yang; Ya Ke
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

8.  Urine proteome analysis in murine nephrotoxic serum nephritis.

Authors:  Scott E Wenderfer; William P Dubinsky; Mayra Hernandez-Sanabria; Michael C Braun
Journal:  Am J Nephrol       Date:  2009-09-24       Impact factor: 3.754

Review 9.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

Review 10.  The roles of antimicrobial peptides in innate host defense.

Authors:  Gill Diamond; Nicholas Beckloff; Aaron Weinberg; Kevin O Kisich
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.